Qualigen Therapeutics Inc (QLGN)
US$ 3.80.53%
Price Chart
Key Statistics
Market Cap
$ 3.39M
P/E Ratio
0.00
Revenue (TTM)
$ 4.98M
Volume
463.25K
52W High
$ 11.50
52W Low
$ 2.00
Dividend Yield
0.00%
Beta
-0.17
Technicals
50-Day MA
3.3929
200-Day MA
3.8809
52 Week High
11.5
52 Week Low
1.9995
About QLGN
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer.
Employees
N/A
Headquarters
Carlsbad, CA
CEO
Mr. Kevin A. Richardson II